entertainment -WSS

entertainment

author：hotspot 2025-09-30 16:28:45 - browse：341

Adam's take main illustration — Molly Ferguson/STAT

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study.

A looming test for neoantigen cancer vaccines

Before the end of the quarter, Gritstone Bio will release preliminary results from a randomized, Phase 2 clinical trial investigating a personalized therapeutic cancer vaccine in microsatellite-stable colon cancer, a type of “immunologically cold” tumor that is resistant to immunotherapies like PD-1/PD-L1 inhibitors.

The Gritstone vaccine is designed to train a patient’s own T cells to recognize and kill cancer cells by targeting mutated cancer proteins, called neoantigens, that are unique to a patient’s own tumor. It’s a relatively new approach for cancer vaccines — made possible by powerful and relatively inexpensive genomic sequencing of tumors – that is intended to overcome all the previous failures in the field. Gritstone’s effort is also similar to one being used by Moderna and Merck that has reported encouraging results in melanoma — and is now being investigated in a Phase 3 study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： As AI in medicine takes off, can 'human in the loop' prevent harm?

Wikipedia

hotspot

WSS

Weighted lottery helped low

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Readout Newsletter: CAR

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Male and female sex labels in research insufficient, scientists say

The (many) problems with a new study criticizing cancer screening

explore

entertainment

A looming test for neoantigen cancer vaccines

Wikipedia

How one medical school became remarkably diverse

NIH nominee Bertagnolli will get October confirmation hearing

Affirmative action in medical school literally saved lives

Weighted lottery helped low

Medical records are filled with copy

Ebola: Gilead Sciences antiviral shows promise as new treatment

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Alkermes shareholders re

What drug price negotiations mean for Medicare Part D

hotspot

EPA limits use of carcinogenic gas for sterilizing medical devices

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

The (many) problems with a new study criticizing cancer screening

Amazon on where the company's health care bets are headed next

Covid hospitalizations on the rise, Humana says

How many hemophilia patients actually want gene therapy?

hotspot

hotspot

hotspot

explore